Microbot Medical Inc. announced that it will receive $1,762,502 in funding on June 3, 2024. The company will issue convertible preferred stock warrants to purchase 78,333 common shares exercisable at $1.875 per share in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.